Menu

Opiant Pharmaceuticals, Inc. OPNT

Full chart Compare
Set alert

Price alert · OPNT

All alert types
20.65 +20.65

Day range unavailable

52-week range unavailable

Revenue & Expenses

Other Income → Gross Profit & Other Income: $5.71KGross Profit & Other Income → Net Income: $3.01MGross Profit & Other Income → Selling, General & Admin: $16.73MGross Profit & Other Income → Research & Development: $16.83MGross Profit & Other Income → Other Operating Expenses: $9.07MGross Profit & Other Income → Interest Expense: $2.13MGross Profit & Other Income → Income Tax: $24.27KGross Profit → Gross Profit & Other Income: $47.79MRevenue → Gross Profit: $47.79MOther Income$5.71KGross Profit$47.79MGross Profit & Other Income$47.79MNet Income$3.01MSelling, General & Admin$16.73MResearch & Development$16.83MOther Operating Expenses$9.07MInterest Expense$2.13MIncome Tax$24.27KRevenue$47.79M

Latest period ending Dec 31, 2021 · select a line to chart its full history

Annual income statement

OPNT annual income statement
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Jul 31, 2017
47.79M29.63M40.52M13.98M18.45M
47.79M29.63M40.52M13.98M18.45M
47.79M29.63M40.52M13.98M18.45M
42.63M31.87M29.61M35.17M11.35M
16.83M9.24M9.08M8.48M3.17M
16.73M16.43M12.81M11.48M8.18M
5.16M-2.24M10.91M-21.19M7.09M
2.13M131.01K000
24.27K-425.68K-177.24K51.28K550.47K
3.01M-1.86M11.59M-21.20M6.58M
3.01M-1.86M11.59M-21.20M6.58M
3.01M-1.86M11.59M-21.20M6.58M
3.01M-1.86M11.59M-21.20M6.58M
0.68-0.442.88-7.103.27
0.68-0.442.88-7.103.27
0.51-0.442.17-7.102.94
5.16M-2.16M11.42M-21.14M7.13M
5.16M-2.16M11.42M-21.14M7.13M
4.46M4.25M4.02M2.99M2.01M
5.92M4.25M5.34M2.99M2.24M